Filter
1273
Filtered Results: 1273
Text search:
molecular
testing
Featured
Recommendations
170
New Publications
271
Language
Document type
No document type
610
Guidelines
266
Studies & Reports
218
Manuals
68
Strategic & Response Plan
56
Fact sheets
27
Training Material
14
Situation Updates
9
Resource Platforms
2
Infographics
2
Brochures
1
Countries / Regions
India
80
Western and Central Europe
44
Global
37
Latin America and the Carribbean
32
Africa
29
Kenya
28
Eastern Europe
24
Tanzania
22
South Africa
22
Ethiopia
20
Brazil
18
Germany
16
Nigeria
14
West and Central Africa
14
East and Southern Africa
14
Sierra Leone
13
Malawi
12
Rwanda
11
Uganda
11
Russia
11
Philippines
10
South–East Asia Region
10
Colombia
9
Peru
9
Zambia
9
Indonesia
9
Liberia
9
Nepal
8
Zimbabwe
8
Asia
8
Namibia
8
Mozambique
7
Congo, Democratic Republic of
7
Argentina
7
Bangladesh
6
Myanmar / Burma
6
Ukraine
5
Ghana
5
Syria
5
Senegal
5
USA
5
Middle East and North Africa
5
Western Pacific Region
5
Eastern Europe and Central Asia
5
Angola
5
Burkina Faso
4
Ecuador
4
Pakistan
4
El Salvador
3
Chile
3
Cambodia
3
Guinea-Bissau
3
Spain
3
Lebanon
3
Vietnam
3
Botswana
3
South Sudan
3
Eswatini/ Swaziland
3
Tajikistan
2
Lesotho
2
Turkey
2
Benin
2
Cameroon
2
Guinea
2
Italy
2
Venezuela
2
Bolivia
2
Georgia
2
North Macedonia
1
Switzerland
1
Timor Leste/ East Timor
1
Mexico
1
Gambia
1
Afghanistan
1
Haiti
1
Dominican Republic
1
Jordan
1
North America
1
Gabon
1
Turkmenistan
1
France
1
United Kingdom
1
Portugal
1
Latvia
1
Nicaragua
1
Palestine
1
Honduras
1
Iraq
1
Somalia
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
403
Clinical Guidelines
179
Pharmacy & Technologies
53
Public Health
48
Key Resources
23
Women & Child Health
20
Capacity Building
5
Toolboxes
TB
264
COVID-19
173
AMR
107
HIV
85
NTDs
67
Rapid Response
62
Ebola
36
Mental Health
31
Planetary Health
29
Pharmacy
27
Zika
20
Refugee
16
NCDs
14
Polio
12
Specific Hazards
11
Caregiver
6
Cholera
5
Health Financing Toolbox
5
Conflict
5
Natural Hazards
4
Disability
4
Global Health Education
3
Social Ethics
1
New funding requirements: CHF 2.8 billion IFRC-wide of which CHF 670 million is channelled through the IFRC Emergency Appeal in support of National Societies
In 2007, WHO warned that infectious diseases are emerging and re-emerging at a rate that has not been seen before. The potential for infectious diseases to spread rapidly results in high morbidity and mortality, causing a potential global public health treat of major concern.
Several factors are ...
31 Oct 2022 his plan outlines how the ACT-Accelerator will support countries as the world transitions to long-term COVID-19 control.
Recognizing the evolving nature of the COVID-19 virus and pandemic, the plan outlines changes to ACT-A’s set-up and ways of working, to ensure countries co...
Responding to Outbreaks of Antimicrobial-resistant Pathogens in Health-care Facilities: Guidance for the Western Pacific Region is developed following requests from Member States in the Western Pacific Region for additional information and support in managing AMR outbreaks. It aims to provide: a ste...
January 2020 to December 2021
This Mpox SPRP Global Monitoring & Evaluation (M&E) Framework, also referred to as the Framework, aims to monitor and report on global progress towards these objectives, including information about country-level response efforts and WHO support to Member States. Regular collection and analysis of da...
Yaws is a disfiguring non-venereal disease caused by infection with the spirochaete. Treponema pallidum subspecies pertenue which is closely related to the causative agent of syphilis and those of the other endemic treponematoses, bejel and pinta. The disease is endemic in certain areas of the World...
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr...
Regional implementation framework for elimination of cervical cancer as a public health problem: 2021–2030
recommended
Cervical cancer continues to be a significant public health problem and a major cause of premature mortality among women, disproportionately affecting the socioeconomically disadvantaged population in low- and middle-income countries (LMICs). In the absence of implementing the known evidence-based, ...
As a global community of +750 representatives of the world’s civil society, the C20 official Engagement Group of the G20 is submitting a list of policy priorities for the upcoming G20 Finance Ministers & Central Bank Governors meeting on July 18th and the G20 Extraordinary Sherpa Meeting on July 2...
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
The key actions, activities, and approaches in this document are organized within each of the 5Cs (see Table 1 in the PDF) and those of the Strategic preparedness and response plan (SPRP) pillars as follows:
National action plan key activities, prioritized for the current context and the current ...
Cancer centres are a major resource in ensuring a comprehensive approach to cancer treatment and its planning. As part of a new roadmap developed by WHO and IAEA to help countries design national cancer control programmes, this publication proposes a framework to develop a cancer centre and/or to st...
Public Health Action
vol 5 no 3 published 21 september 2015
The main objectives of the SOPs are to: (i) establish standards and timelines for response activities; and (ii) guide national governments and GPEI partners in key support functions.
This new version of the SOPs presents overall response requirements for dealing with type 1, 2 and 3 poliovirus fo...
